Provided by Tiger Trade Technology Pte. Ltd.

Binah Capital Group Inc

1.25
-0.0200-1.58%
Volume:24.04K
Turnover:30.64K
Market Cap:21.31M
PE:8.92
High:1.36
Open:1.26
Low:1.23
Close:1.27
52wk High:3.44
52wk Low:1.20
Shares:17.06M
Float Shares:3.44M
Volume Ratio:1.45
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1400
EPS(LYR):0.0400
ROE:22.43%
ROA:6.00%
PB:6.57
PE(LYR):31.23

Loading ...

Binah Capital Group announces annual shareholder meeting

Reuters
·
May 01

Big Four giant EY set to bolster AI recruitment

cityam
·
Apr 28

Press Release: Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting

Dow Jones
·
Apr 28

Ares Commercial Finance, Platinum funds finance Kingswood acquisition of Daramic

Reuters
·
Apr 27

Berenberg Bank Sticks to Its Buy Rating for Baltic Classifieds Group Plc (BCG)

TIPRANKS
·
Apr 23

AI Now Accounts for a Quarter of BCG's Revenue as Overall Growth Slows to 7%

Deep News
·
Apr 23

AI-focused services make up 40 per cent of BCG’s 2025 revenue

cityam
·
Apr 23

ImmunityBio Stock Rises As ANKTIVA Launches in Saudi Arabia

Benzinga_recent_news
·
Apr 21

Exclusive: Consulting Giant BCG Picks New Head of North America -- WSJ

Dow Jones
·
Apr 16

Binah Capital promotes Christopher Motta to World Equity Group president

Reuters
·
Apr 10

Wall Street Set to Open Higher as Trump Says US Will Consider Ceasefire if Hormuz Strait Opened

MT Newswires Live
·
Apr 01

Top Premarket Gainers

MT Newswires Live
·
Apr 01

Chief executives blame sleepless nights on their own senior team

cityam
·
Apr 01

Binah Capital Group (BCG) Stock Surges 59% After Hours — Here's Why

Benzinga Earnings
·
Apr 01

Binah Capital Group Q4 EPS $0.01 Up From $(0.07) YoY, Sales $50.512M Up From $44.608M YoY

Benzinga Earnings
·
Apr 01

Press Release: Binah Capital Group Reports Results for Fourth Quarter and Full Year 2025

Dow Jones
·
Apr 01

Binah Capital FY25 net income rises to $2.3 million; revenue increases 10.7% to $187.1 million

Reuters
·
Apr 01

ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check

Benzinga
·
Mar 26

OpenAI Offers Superior Terms to PE Firms in Race Against Anthropic for Corporate AI

Deep News
·
Mar 24

ImmunityBio Stock Jumps As New Bladder Cancer Guideline Boosts Anktiva Use

Benzinga_recent_news
·
Mar 18